Spanish Interpretation available for this session. Please click on the Web Links tab at bottom of screen to link out to live interpretation.
Plenary
P2 - It Takes Everyone: Novel CF Therapeutics & Clinical Trial Strategy to Accelerate our Mission
Friday, November 4, 2022
2:00 PM – 3:15 PM ET
Location: Terrace Ballroom
Significant progress has been made in the last two decades to advance therapies for people with CF, transforming the lives of many individuals with the disease. However, there is still a critical need for innovative new therapies to treat the underlying cause of CF as well as the many complications of the disease. Plenary 2 will discuss clinical trial advances in the CF therapeutics pipeline and highlight the diverse strategies being implemented to address the needs of all people with CF. Deepika Polineni, MD, MPH, will review past and current drug trials that are targeting the needs of people with CF via a multi-organ approach. Nicole Mayer Hamblett, PhD, will provide an overview of the comprehensive clinical trial strategy to enable novel therapeutics and optimal treatment regimens to quickly advance, furthering our mission of ensuring all with CF will live long, healthy lives.
Educational Objectives:
Describe the recent advances in potential therapies focused on correcting the underlying defect in cystic fibrosis.
Describe the types of clinical trials in our pipeline supporting a population with CF with different needs and until curative disease-modifying therapies are realized for all.
Demonstrate the impact of trial participation on advancing the entire therapeutic pipeline through novel study designs and the unification of data.